A Twelve Week Study of Supervised Mouth Rinse and Flossing

Launched by JOHNSON & JOHNSON CONSUMER INC. (J&JCI) · Jan 4, 2021

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Able to comprehend and follow the requirements and restrictions of the study (including willingness to use the assigned study products according to instructions, availability on scheduled visit dates and likeliness of completing the clinical study) based upon research site personnel's assessment
• • Able to attend once daily session during weekdays for flossing and rinsing occurring on site
• • Evidence of a personally signed and dated informed consent document indicating the subject (or legally acceptable representative) has been informed of all pertinent aspects of the trial
• • Able to read and understand the local language (participants capable of reading the documents)
• • Adequate oral hygiene (that is brush teeth daily and exhibit no signs or oral neglect)
• • A minimum of 20 natural teeth with scorable facial and lingual surfaces. Teeth that are grossly carious, extensively restored, orthodontically banded, abutments, exhibiting severe generalized cervical and/or enamel abrasion, or third molars will not be included in the tooth count
• • A minimum of 10 bleeding sites based on the BI
• • Absence of advanced periodontitis based on a clinical examination at Baseline and discretion of the dental examiner
• Exclusion criteria:
• • History of significant adverse effects, including sensitivities or suspected allergies, following use of oral hygiene products such as toothpastes, mouth rinses and red food dye
• • Dental prophylaxis within four weeks prior to Screening/Baseline visit
• • History of medical conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
• • Antibiotic, anti-inflammatory or anticoagulant therapy during the study or within the one month prior to the Baseline exam. Intermittent use of certain anti-inflammatory medication is acceptable at the discretion of the Investigator
• • Use of chemotherapeutic anti-plaque/anti-gingivitis products such as triclosan, essential oils, cetylpyridinium chloride, stannous fluoride or chlorhexidine containing mouth rinses within the two weeks prior to Baseline